ISRCTN25817033已完成不适用
The Shoulder Window of Opportunity Study
West Yorkshire Primary Care Research and Development Unit (UK)0 个研究点目标入组 220 人开始时间: 2006年5月11日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 220
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Age 40 years or older with unilateral shoulder pain. Shoulder pain is defined as pain in the shoulder region, including the upper arm, elicited or exacerbated by active or passive shoulder movement.br/>2. Subject rating of pain as moderate or severe on a 3-point scale (mild/moderate/severe)
- •3. Non-capsular pattern of restriction where capsular pattern is defined as painful and limited passive glenohumeral mobility, lateral rotation must be relatively more restricted than abduction and medial rotation. Some loss of lateral rotation permitted but no more than 25% compared to opposite side.
- •4. Positive impingement test (Hawkins or Neer)
排除标准
- •1. Unable to give informed consent
- •2. Known blood coagulation disorders
- •3. Evidence of referred pain from the cervical spine or internal organs
- •4. Neurological abnormality of the shoulder
- •5. History of rheumatoid arthritis, polymyalgia rheumatica or other inflammatory arthritis
- •6. Bilateral shoulder pain
- •7. Contraindications to local steroid/lidocaine injection
- •8. Pregnancy or breastfeeding
- •9. Previous fracture, dislocation or surgery to shoulder, upper limb, neck, or thorax
- •10. No previous steroid injections in the symptomatic shoulder in the previous 6 months
- •11. No previous physiotherapy for the symptomatic shoulder in the previous 6 months
研究者
相似试验
进行中(未招募)
1 期
The Shoulder Window of Opportunity Study (SWOP) - A pragmatic randomised trial comparing corticosteroid injection with timely physiotherapy with physiotherapy alone for older subjects with subacromial impingement syndrome and moderate to severe pain and disability. - The SWOP StudySubacromial impingement syndromeEUCTR2005-003628-20-GBWest Yorkshire Primary Care R&D Unit220
招募中
1 期
PREOPERATIVE WINDOW OF OPPORTUNITY STUDY WITH GIREDESTRANT (GDC-9545) OR TAMOXIFEN IN PREMENOPAUSAL WOMEN WITH ER[+]/HER2[-] & KI67=10% EARLY BREAST CANCERCTIS2023-503565-36-00Medica Scientia Innovation Research S.L.92
尚未招募
不适用
A window of opportunity study for investigating drug tolerant persister (DTP) to preoperative Brigatinib in resectable non-small cell lung cancer (NSCLC) harboring ALK fusions.KCT0007384Yonsei University Health System, Severance Hospital12
进行中(未招募)
不适用
A window of opportunity study for investigating drug tolerant persister (DTP) to neoadjuvant osimertinib in resectable non-small cell lung cancer (NSCLC) harbouring EGFR mutationsNeoplasmsKCT0005853Yonsei University Health System, Severance Hospital25
尚未招募
Unknown
A study to identify the lost possibilities for end of life care discussion and the impact on health among the patients admitted to intensive care unitCTRI/2023/12/060601Shwetha
